All News

2020

January

San Francisco bridge by Joseph Barrientos @jbcreate_/Unsplash

Novartis @ J.P Morgan 2020

From January 13th to 16th 2020, Novartis is attending the J.P Morgan Healthcare Conference in San Francisco.

2019

December

AVXS-101 Managed Access Program - letter to the SMA community

Experts discuss the global impact of sickle cell disease

Uncovering profound and under-reported effects on people living with sickle cell disease

Results of the Sickle Cell World Assessment Survey (SWAY) highlight the impact this debilitating disease has on patients and their families.

A Novartis scientist adjusting equipment in a drug research lab

Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.

Amazon Web Services (AWS) announces strategic collaboration with Novartis to accelerate digital transformation of its business operations

We’re collaborating with AWS to build an enterprise-wide data and analytics platform to transform the way medicines are manufactured and delivered.

Two Novartis scientists collaborating in a research lab

Behind the research driving our data at medical conferences

Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.